Thursday, January 15, 2015

Continuous Processing The Good, The Bad and the Unexpected

Continuous processing is easier said, than done. It promises to make biomanufacturing more viable,
but will it delver?

At BDP Week, industry experts will share the good, the bad and the unexpected to help you reduce manufacturing costs, improve product quality and increase flexibility while reducing risks.

Continuous Processing Programming Highlights Include:
  • • Media Development Strategies for Platform and Late Phase Cell Culture Process
    • -Wenge Wang, Ph.D., Senior Principal Scientist, Bioprocess R&D, Pfizer
  • • Upstream Disposable Technology Supports the Implementation of Continuous Processing
    • -Shaun P. Eckerle, Principal Scientist, Cell Culture Development, Patheon Biologics
  • • Downstream Processing and New Technology for Continuous Chromatography
    • -Maria Ekblom, Senior Project Manager, Chromatography Systems, GE Healthcare
  • • Ultra Scale-Down Characterization Of Bioprocessing Materials for the Early Prediction of the Impacts of Industrial Scale Continuous Centrifugation on the Recovery and Purification of New Therapeutic Candidates
    • -Alex Chatel, Ph.D., Bioprocess Enterprise Fellow, Biochemical Engineering, University College London, United Kingdom
  • • Continuous Chromatography: The Good, the Bad, and the Unexpected
    • -Oliver Kaltenbrunner, Ph.D., Scientific Director, Chemical Process R&D, Amgen
  • • How to Optimize the Perfusion Rate in High Cell Density Perfusion of Chinese Hamster Ovary Cells Culture in Stirred Tank
    • -Veronique Chotteau, Ph.D., Prinicpal Investigator, Researcher, Cell Technology Group, School of Biotechnology, KTH, Royal Institute of Technology, Sweden
  • • Integrated and Fully Continuous Processing of Recombinant Therapeutic Proteins – From Cell Culture Media to Purified Drug Substance
    • -Veena Warikoo, Ph.D., Director, Purification Development, Genzyme
  • • Exploring Options for Achieving Diafiltration in a Continuous Process
    • -Alex Brinkmann, Engineer III, Biogen Idec
  • • ASAP (Automated Seamless Antibodies Purification): Toward a Fully-Disposable Process
    • -Benoit Mothes, Pharm D, Senior DSP Scientist, Sanofi, France
  • • Continuous Downstream Processing: Where Does It Fit?
    • -Moderator: Marc Bisschops, Ph.D., Scientific Director, Tarpon Biosystems
  • • Single-Use Chromatography Platform For Monoclonal Antibody Purification
    • -Renaud Jacquemart, Ph.D., Senior Scientist, Process Sciences, Natrix Separations
  • • Exploring Options for Achieving Diafiltration in a Continuous Process
    • -Alex Brinkmann, Engineer III, Biogen Idec
  • • Processes of the Future : Single Use, Closed and Continuous for Faster, Cheaper and Safer Manufacturing
    • -S├ębastien Ribault, Ph.D., Director Biotechnology/Life Science, Head of BioDevelopment Center, EMD Millipore

Plus, do you have new research to share with your industry colleagues? We’re searching for the newest, innovative findings to be presented by our attendees in poster displays at BDP Week. Submit your abstract today.

Now is the time to make plans not attend BDP Week for end-to-end bioprocessing solutions that will help you guarantee reproducible results and manufacturing success.  Register to join us March 30-April 2, 2015 in Huntington Beach, California.  As a reader of this blog, when you register to join us and mention code XB15155BLOGJP, you save 20% off standard rates.


Share this article with your social network, just click below to share now!


No comments :

Post a Comment